Drugs / Rikkunshito
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT03856294 | Dec 2015 → Oct 2018 | dyspepsia | Universitaire Ziekenhuizen KU Leuven | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT06482671 Comparator | Oct 2024 → Oct 2026 expected | dyspepsia, intestinal dysmotility syndrome | Universitaire Ziekenhuizen KU Leuven | Recruiting | No outcome recorded |
| Phase 4 | NCT02037776 Comparator | Apr 2014 → Mar 2016 | dyspepsia | Osaka City University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rikkunshito | “Previously the efficacy of the Kampo medicine Rikkunshito (TJ-43) has been shown in FD.” NCT06482671 ↗ |
| Known as | TJ-43 | “Previously the efficacy of the Kampo medicine Rikkunshito (TJ-43) has been shown in FD.” NCT06482671 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Rikkunshito, a traditional Japanese Kampo medicine” NCT03856294 ↗ |
| Route | Oral | “Oral administration of rikkunshito” NCT02037776 ↗ |